Korea Opioid Induced Constipation (OIC) Drugs Market Research Report 2018

Publisher Name :
Date: 12-Apr-2018
No. of pages: 110
Inquire Before Buying

The global Opioid Induced Constipation (OIC) Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Korea plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Opioid Induced Constipation (OIC) Drugs development status and future trend in Korea, focuses on top players in Korea, also splits Opioid Induced Constipation (OIC) Drugs by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in Korea market include

- Ironwood Pharmaceuticals Inc

- Daiichi Sankyo Co Ltd

- Pfizer

- Progenics Pharmaceuticals Inc

- Shionogi & Co., Ltd

- Allergan Plc

- Nektar Therapeutics

- Purdue Pharma

- S.L.A. Pharma AG

- Mundipharma International Limited

- Ono Pharmaceutical Co., Ltd

- Takeda Pharmaceutical Company Limited

- Theravance Biopharma Inc

- Valeant Pharmaceuticals International

- Cosmo Pharmaceuticals SA

- Daewoong Pharmaceutical

- C.B. Fleet Company

- Sucampo Pharmaceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

- By Drug Type

- - Lubiprostone

- - Methyl Naltrexone Bromide

- - Naldemedine

- - Alvimopan

- - Other

- By Prescription Type

- - Generic and Branded Prescribed Drugs

- - Over The Counter Drugs

On the basis of the end users/Application, this report covers

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Korea Opioid Induced Constipation (OIC) Drugs Market Research Report 2018

Table of Contents
Korea Opioid Induced Constipation (OIC) Drugs Market Research Report 2018
1 Opioid Induced Constipation (OIC) Drugs Overview
1.1 Product Overview and Scope of Opioid Induced Constipation (OIC) Drugs
1.2 Classification of Opioid Induced Constipation (OIC) Drugs by Product Category
1.2.1 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Comparison by Type (2013-2025)
1.2.2 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Market Share by Type in 2017
1.2.3 Lubiprostone
1.2.4 Methyl Naltrexone Bromide
1.2.5 Naldemedine
1.2.6 Alvimopan
1.2.7 Other
1.3 Korea Opioid Induced Constipation (OIC) Drugs Market by Application/End Users
1.3.1 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Korea Revenue and Sales of Opioid Induced Constipation (OIC) Drugs (2013-2025)
1.4.1 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2025)
1.4.2 Korea Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 Korea Opioid Induced Constipation (OIC) Drugs Market Competition by Players/Manufacturers
2.1 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 Korea Opioid Induced Constipation (OIC) Drugs Revenue and Share by Players/Manufacturers (2013-2018)
2.3 Korea Opioid Induced Constipation (OIC) Drugs Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 Korea Opioid Induced Constipation (OIC) Drugs Market Competitive Situation and Trends
2.4.1 Korea Opioid Induced Constipation (OIC) Drugs Market Concentration Rate
2.4.2 Korea Opioid Induced Constipation (OIC) Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in Korea Market
2.5 Korea Players/Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution, Sales Area, Product Type
3 Korea Opioid Induced Constipation (OIC) Drugs Sales and Revenue (Value) by Type (2013-2018)
3.1 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
3.2 Korea Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 Korea Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) by Type (2013-2018)
3.4 Korea Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (%) by Type (2013-2018)
4 Korea Opioid Induced Constipation (OIC) Drugs Sales by Application (2013-2018)
4.1 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Market Share by Application (2013-2018)
4.2 Korea Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities
5 Korea Opioid Induced Constipation (OIC) Drugs Players/Suppliers Profiles and Sales Data
5.1 Ironwood Pharmaceuticals Inc
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
5.1.2.1 Product A
5.1.2.2 Product B
5.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.1.4 Main Business/Business Overview
5.2 Daiichi Sankyo Co Ltd
5.2.1 Company Basic Information, Manufacturing Base and Competitors
5.2.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
5.2.2.1 Product A
5.2.2.2 Product B
5.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.2.4 Main Business/Business Overview
5.3 Pfizer
5.3.1 Company Basic Information, Manufacturing Base and Competitors
5.3.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
5.3.2.1 Product A
5.3.2.2 Product B
5.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.3.4 Main Business/Business Overview
5.4 Progenics Pharmaceuticals Inc
5.4.1 Company Basic Information, Manufacturing Base and Competitors
5.4.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
5.4.2.1 Product A
5.4.2.2 Product B
5.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.4.4 Main Business/Business Overview
5.5 Shionogi & Co., Ltd
5.5.1 Company Basic Information, Manufacturing Base and Competitors
5.5.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
5.5.2.1 Product A
5.5.2.2 Product B
5.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.5.4 Main Business/Business Overview
5.6 Allergan Plc
5.6.1 Company Basic Information, Manufacturing Base and Competitors
5.6.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
5.6.2.1 Product A
5.6.2.2 Product B
5.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.6.4 Main Business/Business Overview
5.7 Nektar Therapeutics
5.7.1 Company Basic Information, Manufacturing Base and Competitors
5.7.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
5.7.2.1 Product A
5.7.2.2 Product B
5.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.7.4 Main Business/Business Overview
5.8 Purdue Pharma
5.8.1 Company Basic Information, Manufacturing Base and Competitors
5.8.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
5.8.2.1 Product A
5.8.2.2 Product B
5.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.8.4 Main Business/Business Overview
5.9 S.L.A. Pharma AG
5.9.1 Company Basic Information, Manufacturing Base and Competitors
5.9.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
5.9.2.1 Product A
5.9.2.2 Product B
5.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.9.4 Main Business/Business Overview
5.10 Mundipharma International Limited
5.10.1 Company Basic Information, Manufacturing Base and Competitors
5.10.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
5.10.2.1 Product A
5.10.2.2 Product B
5.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.10.4 Main Business/Business Overview
5.11 Ono Pharmaceutical Co., Ltd
5.12 Takeda Pharmaceutical Company Limited
5.13 Theravance Biopharma Inc
5.14 Valeant Pharmaceuticals International
5.15 Cosmo Pharmaceuticals SA
5.16 Daewoong Pharmaceutical
5.17 C.B. Fleet Company
5.18 Sucampo Pharmaceuticals
6 Opioid Induced Constipation (OIC) Drugs Manufacturing Cost Analysis
6.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Opioid Induced Constipation (OIC) Drugs Major Manufacturers in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 Korea Opioid Induced Constipation (OIC) Drugs Market Size (Sales and Revenue) Forecast (2018-2025)
10.1 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
10.2 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Type (2018-2025)
10.3 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Application (2018-2025)
11 Research Findings and Conclusion
List of Tables and Figures
Figure Korea Market Size (Million USD) Status and Outlook (2013-2025)
Table Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2017-2025)
Figure Product Picture of Opioid Induced Constipation (OIC) Drugs
Table Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type in 2017
Figure Lubiprostone Product Picture
Figure Methyl Naltrexone Bromide Product Picture
Figure Naldemedine Product Picture
Figure Alvimopan Product Picture
Figure Other Product Picture
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Comparison by Application (2013-2025)
Figure Korea Sales Market Share (%) of Opioid Induced Constipation (OIC) Drugs by Application in 2017
Figure Hospital Pharmacies Examples
Figure Retail Pharmacies Examples
Figure Online Pharmacies Examples
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure Korea Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Korea Opioid Induced Constipation (OIC) Drugs Sales of Key Players/Manufacturers (2013-2018)
Table Korea Opioid Induced Constipation (OIC) Drugs Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Korea Opioid Induced Constipation (OIC) Drugs Sales Share (%) by Players/Manufacturers
Figure 2017 Korea Opioid Induced Constipation (OIC) Drugs Sales Share (%) by Players/Manufacturers
Table Korea Opioid Induced Constipation (OIC) Drugs Revenue by Players/Manufacturers (2013-2018)
Table Korea Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Korea Opioid Induced Constipation (OIC) Drugs Revenue Share (%) by Players/Manufacturers
Figure 2017 Korea Opioid Induced Constipation (OIC) Drugs Revenue Share (%) by Players/Manufacturers
Table Korea Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Pcs) of Key Players/Manufacturers (2013-2018)
Figure Korea Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Pcs) of Key Players/Manufacturers in 2017
Figure Korea Opioid Induced Constipation (OIC) Drugs Market Share of Top 3 Players/Manufacturers
Figure Korea Opioid Induced Constipation (OIC) Drugs Market Share of Top 5 Players/Manufacturers
Table Korea Players/Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution and Sales Area
Table Korea Players/Manufacturers Opioid Induced Constipation (OIC) Drugs Product Category
Table Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2013-2018)
Table Korea Opioid Induced Constipation (OIC) Drugs Sales Share (%) by Type (2013-2018)
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Share (%) by Type (2013-2018)
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2017
Table Korea Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Korea Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2013-2018)
Figure Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Type in 2017
Table Korea Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) by Type (2013-2018)
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (%) by Type (2013-2018)
Table Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2013-2018)
Table Korea Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application (2013-2018)
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application (2013-2018)
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2017
Table Korea Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (%) by Application (2013-2018)
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (%) by Application (2013-2018)
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in Korea (2013-2018)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in Korea (2013-2018)
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in Korea (2013-2018)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in Korea (2013-2018)
Table Pfizer Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in Korea (2013-2018)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in Korea (2013-2018)
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in Korea (2013-2018)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in Korea (2013-2018)
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in Korea (2013-2018)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in Korea (2013-2018)
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in Korea (2013-2018)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in Korea (2013-2018)
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in Korea (2013-2018)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in Korea (2013-2018)
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in Korea (2013-2018)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in Korea (2013-2018)
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Basic Information List
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in Korea (2013-2018)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in Korea (2013-2018)
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in Korea (2013-2018)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in Korea (2013-2018)
Table Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Valeant Pharmaceuticals International Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Basic Information List
Table C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid Induced Constipation (OIC) Drugs
Figure Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
Figure Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Opioid Induced Constipation (OIC) Drugs Major Players/Manufacturers in 2017
Table Major Buyers of Opioid Induced Constipation (OIC) Drugs
Table Distributors/Traders List
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Korea Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Korea Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) Trend Forecast (2018-2025)
Table Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Type (2018-2025)
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Type (2018-2025)
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share Forecast by Type in 2025
Table Korea Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Application (2018-2025)
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share Forecast by Application (2018-2025)
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share Forecast by Application in 2025
  • Korea Tissue Engineered Bone Market Research Report 2018
    Published: 25-Apr-2018        Price: US 3400 Onwards        Pages: 100
    The global Tissue Engineered Bone market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Korea plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Tissue Engineered Bone development status and future trend in Korea, focuses on top players in Korea, also splits ......
  • Mexico 7-Aminocephalosporanic Acid (7-ACA) Market Research Report 2018
    Published: 25-Apr-2018        Price: US 3400 Onwards        Pages: 96
    The global 7-Aminocephalosporanic Acid (7-ACA) market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Mexico plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the 7-Aminocephalosporanic Acid (7-ACA) development status and future trend in Mexico, focuses on top pl......
  • Global Bioactive Wound Management Market Professional Survey Report 2018
    Published: 25-Apr-2018        Price: US 3500 Onwards        Pages: 101
    This report studies Bioactive Wound Management in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Acelity L.P. - Smith & Nephew - MiMedx Group - 3M ......
  • Mexico Bromodomain Testis Specific Protein Market Research Report 2018
    Published: 25-Apr-2018        Price: US 3400 Onwards        Pages: 95
    The global Bromodomain Testis Specific Protein market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Mexico plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Bromodomain Testis Specific Protein development status and future trend in Mexico, focuses on top pl......
  • Global Veterinary Therapeutics Market Professional Survey Report 2018
    Published: 25-Apr-2018        Price: US 3500 Onwards        Pages: 101
    This report studies Veterinary Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Bayer AG - Boehringer Ingelheim GmbH - Ceva Sante Animale -......
  • Mexico Gelatin Type Hard Capsules Market Research Report 2018
    Published: 25-Apr-2018        Price: US 3400 Onwards        Pages: 105
    The global Gelatin Type Hard Capsules market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Mexico plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Gelatin Type Hard Capsules development status and future trend in Mexico, focuses on top players in Mexico, a......
  • Global Human Papillomavirus Protein E6 Sales Market Report 2018
    Published: 25-Apr-2018        Price: US 4000 Onwards        Pages: 113
    This report studies the global Human Papillomavirus Protein E6 market status and forecast, categorizes the global Human Papillomavirus Protein E6 market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). In 2017, the global Human Papillomavirus Protein E6 market size was xx million US$ and it is exp......
  • Global Human Plasma-Derived Therapeutics Sales Market Report 2018
    Published: 25-Apr-2018        Price: US 4000 Onwards        Pages: 115
    This report studies the global Human Plasma-Derived Therapeutics market status and forecast, categorizes the global Human Plasma-Derived Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). In 2017, the global Human Plasma-Derived Therapeutics market size was xx million US$ and it ......
  • Global Idiopathic Short Stature Drug Sales Market Report 2018
    Published: 25-Apr-2018        Price: US 4000 Onwards        Pages: 104
    This report studies the global Idiopathic Short Stature Drug market status and forecast, categorizes the global Idiopathic Short Stature Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). In 2017, the global Idiopathic Short Stature Drug market size was xx million US$ and it is expected ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs